- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech High Growth Potential Companies
Danish Pharmaceuticals & Biotech High Growth Potential Companies
Results
4
Companies with a Future performance score of at least 3, ordered by Future performance score.
4 companies
ChemoMetec
Market Cap: DKK 13.7b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 789.50
7D
9.4%
1Y
98.1%
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 315.30
7D
-7.3%
1Y
-58.1%
Genmab
Market Cap: DKK 114.8b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,864.50
7D
-0.3%
1Y
20.1%
ALK-Abelló
Market Cap: DKK 46.8b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 211.40
7D
-1.7%
1Y
30.7%